乳腺MRI皮肤增厚与强化同无转移生存相关:回顾性分析
该单中心回顾性研究纳入214个超声可见乳腺病灶的 pretreatment MRI,评估MRI征象与无转移生存(MFS)的关系。中位随访5.6年,212例中21例(10%)发生远处转移。皮肤增厚(p=0.043)和皮肤强化(p=0.016)均与较差MFS相关,病灶大小、肿块总合、总病变范围及腋窝异常淋巴结亦相关。
要点
- 乳腺MRI皮肤强化与皮肤增厚可能与较差的无转移生存相关。
- 原发灶大、肿块总和大、总病变范围大及腋窝异常淋巴结也与较差MFS相关。
- 阅片时应关注皮肤增厚与强化,并纳入报告以辅助预后评估。
关键影像表现/征象
- MRI可见皮肤增厚和皮肤强化,并记录非肿块强化(NME)及异常淋巴结、肿块特征、病灶周围水肿和背景实质强化。
- 皮肤增厚者MFS较差:30例中24例(80%)vs 184例中169例(92%),p=0.043。
- 皮肤强化者MFS较差:20例中15例(75%)vs 194例中178例(92%),p=0.016。
- 腋窝异常淋巴结者MFS较差:66例中55例(83%)vs 148例中138例(93%),p=0.024。
诊断标准与关键数值
- 原发灶大与较差MFS相关:p<0.001,AUC 0.823。
- 肿块总和大与较差MFS相关:p<0.001,AUC 0.813。
- 包括NME的总病变范围增大与较差MFS相关:p<0.001,AUC 0.749。
临床应用与阅片要点
- 阅片时注意评估并报告皮肤增厚与皮肤强化,尤其浸润性乳腺癌患者。
- 结合原发灶大小、肿块总合、总病变范围及腋窝淋巴结状态综合评估预后。
- 本研究为单中心回顾性设计,影像征象判读需结合临床和其他预后因素。
局限性
- 单中心回顾性MRI阅片分析,样本来自超声可见病灶数据库。
- 皮肤增厚和皮肤强化组样本量较小(分别30例和20例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To identify associations between MRI-detected skin thickening and enhancement and metastasis-free survival (MFS) given recent reports of skin thickening on ultrasound being a poorer prognostic indicator.
METHODS: Interrogation of a prospectively collected database of ultrasound-visible breast lesions showed 214 lesions with pre-treatment MRIs available for analysis in a single centre. Data on MFS was prospectively collected. Retrospective MRI review was performed blinded to outcome. Imaging factors recorded were presence of skin thickening and enhancement, non-mass-enhancement (NME) and abnormal nodes, mass characteristics, perilesional oedema and background parenchymal enhancement. Statistical analysis used chi-squared test, Kaplan-Meier survival curves, the Log-rank test and receiver-operator characteristic (ROC) curves.
RESULTS: During a median follow-up period of 5.6 years, 21 (10%) of 212 patients developed distant metastases. Skin thickening [24 of 30 (80%) vs 169 of 184 (92%), p = 0.043] and skin enhancement [15 of 20 (75%) vs 178 of 194 (92%), p = 0.016] were associated with poorer MFS. Large index lesion size [p < 0.001, AUC 0.823], large sum of masses [p < 0.001, AUC 0.813], increasing total lesion extent including NME [p < 0.001, AUC 0.749] and abnormal axillary nodes [55 of 66 (83%) vs 138 of 148 (93%), p = 0.024] were also associated with poorer MFS.
CONCLUSIONS: Skin thickening and enhancement on breast MRI are associated with poorer MFS. These findings should be taken into account when managing patients with invasive breast cancer.
ADVANCES IN KNOWLEDGE: Skin enhancement on breast MRI at diagnosis is associated with metastases development. Skin thickening on breast MRI is associated with future metastatic disease.
引用
- Mberu V, McFarlane J, Macaskill EJ, et al. A retrospective review of MRI features associated with metastasis-free survival in women with breast cancer: focusing on skin thickening and skin enhancement. Br J Radiol. 2021. PMID: 34591686. doi:10.1259/bjr.20210472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。